Sequence-specific bacterial growth inhibition by peptide nucleic acid targeted to the mRNA binding site of 16S rRNA
暂无分享,去创建一个
[1] Huang Xue-wen,et al. Inhibition of bacterial translation and growth by peptide nucleic acids targeted to domain II of 23S rRNA , 2007, Journal of peptide science : an official publication of the European Peptide Society.
[2] K. Tan,et al. Inhibition of Gene Expression and Growth by Antisense Peptide Nucleic Acids in a Multiresistant β-Lactamase-Producing Klebsiella pneumoniae Strain , 2006, Antimicrobial Agents and Chemotherapy.
[3] P. Iversen,et al. Gene-Specific Effects of Antisense Phosphorodiamidate Morpholino Oligomer-Peptide Conjugates on Escherichia coli and Salmonella enterica Serovar Typhimurium in Pure Culture and in Tissue Culture , 2006, Antimicrobial Agents and Chemotherapy.
[4] M. During,et al. Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules , 2006 .
[5] S. Awasthi,et al. Inhibition of Mycobacterium smegmatis Gene Expression and Growth Using Antisense Peptide Nucleic Acids , 2005, Journal of Molecular Microbiology and Biotechnology.
[6] Yin Chen,et al. Peptide Nucleic Acid Antisense Oligomer as a Therapeutic Strategy against Bacterial Infection: Proof of Principle Using Mouse Intraperitoneal Infection , 2005, Antimicrobial Agents and Chemotherapy.
[7] P. Iversen,et al. Antisense Phosphorodiamidate Morpholino Oligomer Length and Target Position Effects on Gene-Specific Inhibition in Escherichia coli , 2005, Antimicrobial Agents and Chemotherapy.
[8] S. Awasthi,et al. Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[9] S. Giovannoni,et al. The uncultured microbial majority. , 2003, Annual review of microbiology.
[10] C. M. Roth,et al. Antisense technology in molecular and cellular bioengineering. , 2003, Current opinion in biotechnology.
[11] D. A. Stein,et al. Inhibition of Gene Expression in Escherichia coli by Antisense Phosphorodiamidate Morpholino Oligomers , 2003, Antimicrobial Agents and Chemotherapy.
[12] D. Corey,et al. Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design. , 2002, Nucleic acids research.
[13] L. Good,et al. Peptide-mediated delivery of green fluorescent protein into yeasts and bacteria. , 2002, FEMS microbiology letters.
[14] V. Ramakrishnan,et al. Recognition of Cognate Transfer RNA by the 30S Ribosomal Subunit , 2001, Science.
[15] Peter E. Nielsen,et al. Bactericidal antisense effects of peptide–PNA conjugates , 2001, Nature Biotechnology.
[16] C. Wahlestedt,et al. Antisense PNA effects in Escherichia coli are limited by the outer-membrane LPS layer. , 2000, Microbiology.
[17] T. Hökfelt,et al. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[18] Ph.D. Michael Loeffelholz,et al. Peptide Nucleic Acids: Protocols and Applications , 2000, Current Microbiology.
[19] P. Nielsen,et al. Inhibition of translation and bacterial growth by peptide nucleic acid targeted to ribosomal RNA. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[20] N. Goldstein,et al. Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Hancock,et al. Peptide antibiotics , 1997, The Lancet.
[22] M. Vaara,et al. Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria , 1996, Antimicrobial agents and chemotherapy.
[23] P. Nielsen,et al. Antisense properties of duplex- and triplex-forming PNAs. , 1996, Nucleic acids research.
[24] V V Demidov,et al. Stability of peptide nucleic acids in human serum and cellular extracts. , 1994, Biochemical pharmacology.
[25] H. Nikaido,et al. Prevention of drug access to bacterial targets: permeability barriers and active efflux. , 1994, Science.
[26] K. Jayaraman,et al. Selective inhibition of Escherichia coli protein synthesis and growth by nonionic oligonucleotides complementary to the 3' end of 16S rRNA. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[27] A. E. Dahlberg,et al. Genetic evidence against the 16S ribosomal RNA helix 27 conformational switch model. , 2004, RNA.
[28] P. Nielsen,et al. The translation start codon region is sensitive to antisense PNA inhibition in Escherichia coli. , 2003, Oligonucleotides.
[29] P. Nielsen,et al. Peptide nucleic acid (PNA) antisense effects in Escherichia coli. , 1999, Current issues in molecular biology.
[30] M. Egholm,et al. An introduction to peptide nucleic acid. , 1999, Current issues in molecular biology.